Breast Nurse Intervention to Improve Adherence to Endocrine Therapy Among Breast Cancer Patients in South Ethiopia

被引:11
|
作者
Getachew, Sefonias [1 ,2 ]
Addissie, Adamu [1 ,2 ]
Seife, Edom [3 ]
Wakuma, Tariku [4 ]
Unverzagt, Susanne [5 ]
Jemal, Ahmedin [6 ]
Taylor, Lesley [7 ]
Wienke, Andreas [2 ]
Kantelhardt, Eva J. [2 ,8 ]
机构
[1] Addis Ababa Univ, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia
[2] Martin Luther Univ Saale, Inst Med Epidemiol Biometr & Informat, Halle, Germany
[3] Addis Ababa Univ, Tikur Anbessa Hosp, Radiotherapy Ctr, Addis Ababa, Ethiopia
[4] Aira Gen Hosp, Dept Surg, Oromia, Ethiopia
[5] Martin Luther Univ Halle Saale, Ctr Hlth Sci, Inst Gen Practice & Family Med, Halle, Germany
[6] Amer Canc Soc, Atlanta, GA 30329 USA
[7] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[8] Martin Luther Univ Halle Wittenberg, Dept Gynaecol, Halle, Germany
来源
ONCOLOGIST | 2022年 / 27卷 / 08期
关键词
breast cancer; adherence; tamoxifen; breast nurse; peripheral hospitals; Ethiopia; SUB-SAHARAN AFRICA; ADJUVANT; WOMEN; TAMOXIFEN; CARE; IMPLEMENTATION; SURVIVORS; INCOME;
D O I
10.1093/oncolo/oyac081
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Many women in rural Ethiopia do not receive adjuvant therapy following breast cancer surgery despite the majority being diagnosed with estrogen-receptor-positive breast cancer and tamoxifen being available in the country. We aimed to compare a breast nurse intervention to improve adherence to tamoxifen therapy for breast cancer patients. Methods and Materials The 8 hospitals were randomized to intervention and control sites. Between February 2018 and December 2019, patients with breast cancer were recruited after their initial surgery. The primary outcome of the study was adherence to tamoxifen therapy by evaluating 12-month medication-refill data with medication possession ratio (MPR) and using a simplified medication adherence scale (SMAQ) in a subjective assessment. Results A total of 162 patients were recruited (87 intervention and 75 control). Trained nurses delivered education and provided literacy material, gave additional empathetic counselling, phone call reminders, and monitoring of medication refill at the intervention hospitals. Adherence according to MPR at 12 months was high in both the intervention (90%) and control sites (79.3%) (P = .302). The SMAQ revealed that adherence at intervention sites was 70% compared with 44.8% in the control sites (P = .036) at 12 months. Persistence to therapy was found to be 91.2% in the intervention and 77.8% in the control sites during the one-year period (P = .010). Conclusion Breast nurses can improve cost-effective endocrine therapy adherence at peripheral hospitals in low-resource settings. We recommend such task sharing to overcome the shortage of oncologists and distances to central cancer centers. In Ethiopia, most patients are estrogen-receptor-positive and could benefit from an endocrine therapy such as tamoxifen; however, endocrine therapy is under-utilized in the country. This article describes a trained breast nurse intervention that was implemented to improve adherence to tamoxifen therapy.
引用
下载
收藏
页码:E650 / E660
页数:11
相关论文
共 50 条
  • [21] Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer
    Bright, Emma E.
    Petrie, Keith J.
    Partridge, Ann H.
    Stanton, Annette L.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 243 - 251
  • [22] Identifying adherence barriers to oral endocrine therapy among breast cancer survivors
    Paranjpe, Rutugandha
    John, Grace
    Trivedi, Meghana
    Abughosh, Susan
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) : 297 - 305
  • [23] Adherence to Antiestrogen Oral Endocrine Therapy Among Older Women With Breast Cancer
    Van Cleave, Janet
    Elstein, Nicole
    Brody, Abraham A.
    NURSING RESEARCH, 2015, 64 (02) : E72 - E72
  • [24] Identifying adherence barriers to oral endocrine therapy among breast cancer survivors
    Rutugandha Paranjpe
    Grace John
    Meghana Trivedi
    Susan Abughosh
    Breast Cancer Research and Treatment, 2019, 174 : 297 - 305
  • [25] Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer
    Emma E. Bright
    Keith J. Petrie
    Ann H. Partridge
    Annette L. Stanton
    Breast Cancer Research and Treatment, 2016, 158 : 243 - 251
  • [26] Male Breast Cancer and Adherence to Adjuvant Endocrine Therapy
    Lee, Inyoung
    Lee, Wan-Ju
    Calip, Gregory S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 189 - 190
  • [27] Non-adherence to endocrine therapy for breast cancer
    Partridge, AH
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 183 - 184
  • [28] Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer
    Calip, Gregory S.
    Xing, Shan
    Jun, Da-Hae
    Lee, Wan-Ju
    Hoskins, Kent F.
    Ko, Naomi Y.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (05) : E451 - E462
  • [29] ADHERENCE TO ENDOCRINE THERAPY IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER
    Bauer, T.
    Ziller, M.
    Holzhauer, W.
    Ziller, V.
    Wagner, U.
    Hadji, P.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4063 - 4063
  • [30] Getting in sync with adherence to endocrine therapy in breast cancer
    Manz, Christopher R.
    CANCER, 2019, 125 (22) : 3917 - 3920